Pharma Journalist - Page 30 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

LNP Innovation Surges as 5th LNP Summit Unveils 2026 Agenda

EU Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Approves AbbVie’s EPKINLY Combination for Relapsed or Refractory Follicular Lymphoma

Genprex Secures U.S. Patent Protecting REQORSA and PD-L1 Antibody Combination

J&J to Acquire Halda Therapeutics in $3.05B Cancer Therapy Deal

EMA Panel Backs High-Dose SPINRAZA Regimen for Spinal Muscular Atrophy

Johnson & Johnson to Acquire Halda Therapeutics for $3.05B to Expand Oncology Pipeline

Merus and Halozyme Partner to Develop Subcutaneous Version of Petosemtamab

Solve Therapeutics Raises $120M to Advance Next-Generation ADC Platform

Sofinnova Partners Closes €650M Fund to Boost Next-Generation Biotech and Medtech Startups